Novartis Contract Manufacturing Capacity Update February 2024: Cell & Gene
Source: Novartis Contract Manufacturing
This presentation from the February 2024 OPCU event provides an overview of the Cell and Gene manufacturing services provided by Novartis Contract Manufacturing and how the in-house capabilities within the Novartis network can support clients' needs in end-to-end production. Gain insight to their new viral vector facility and available capacity in this session.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.
Subscribe to Drug Discovery Online
X
Subscribe to Drug Discovery Online
This website uses cookies to ensure you get the best experience on our website. Learn more